沉默CREB1通过减少RPL9表达和阻断NF-κB信号传递来保护患有深静脉血栓症的老鼠的炎症反应
Xiaorong Jian1, Dehua Yang2, Li Wang3
1Department of Hematology, The Central Hospital of Wuhan, Tongji Medical College, Huazhong University of Science and Technology, No. 26, Shengli Street, Jiang'an District, Wuhan, 430014, Hubei, China. xiaorongjane@126.com.
Journal of cardiovascular translational research
|October 27, 2023
概括
CAMP反应元素结合蛋白1 (CREB1) 通过增加血管内皮细胞亡和炎症来促进深静脉血栓症 (DVT). 抑制CREB1可能为预防DVT提供新的治疗策略.
科学领域:
- 血管生物学 血管生物学
- 分子生物学分子生物学
- 血栓形成的研究研究
背景情况:
- 深静脉血栓症 (DVT) 涉及血管内皮细胞 (VEC) 亡和炎症.
- 转录因子CREB1在静脉血栓塞栓症患者中被上调,可以促进炎症.
- 目前尚不清楚CREB1在DVT发病过程中的具体作用.
研究的目的:
- 为了研究CREB1的生物功能和治疗潜力在DVT的老鼠模型中.
主要方法:
- 在老鼠中通过下腔静脉 (IVC) 狭窄诱导DVT.
- 在DVT模型中,CREB1被淘汰.
- 在体外分析VEC亡.
- 评估血栓形成,炎症,核糖体蛋白L9 (RPL9) 表达和NF-κB通路.
主要成果:
- 在IVC狭窄引起的血栓,炎症和CREB1上调.
- 在CREB1 knockdown显著抑制了DVT大鼠中的血栓形成和炎症.
- 在实验室中,CREB1敲击降低了VEC亡.
- 从机理上讲,CREB1敲击降低了RPL9的表达,并抑制了NF-κB通路.
结论:
- 通过加剧VEC亡和炎症,CREB1在促进DVT方面发挥着关键作用.
- 准CREB1为DVT预防提供了一个潜在的治疗策略.
关键词:
在CREB1中,CREB1是指CREB1,CREB1是指CREB1,CREB1是指CREB1.深静脉血栓形成的原因是深静脉血栓.下腔静脉下腔静脉下部静脉炎症 炎症是一种炎症.在 NF-κBB 中.在RPL9中使用RPL9.更多相关视频
相关概念视频
NF-κB-dependent Signaling Pathway
7.5K
The transcription factor NF-κB was discovered in 1986 in the lab of Nobel laureate Professor David Baltimore, for its interaction with the immunoglobulin light chain enhancer in B-cells. After more than three decades of study, it is now evident that NF-κB regulates the expression of over 100 genes. Most of these genes play an essential role in the innate and adaptive immune responses as well as the inflammatory responses of animals.
NF-κB-dependent Signaling Mechanism
The...
NF-κB-dependent Signaling Mechanism
The...
7.5K
The JAK-STAT Signaling Pathway
8.9K
Several cytokine receptors have tightly bound Janus kinase or JAK proteins attached at their cytosolic tail. Small signaling molecules such as cytokines, growth hormones, or prolactins bind to the cytokine receptors and initiate their dimerization. The dimerization brings the cytosolic JAKs together that trans-phosphorylate and activates each other. The activated JAKs now phosphorylate cytosolic tails of the cytokine receptors, which serve as binding sites for adaptor proteins such as SH2...
8.9K
Regulation of the Unfolded Protein Response
2.4K
Inositol-requiring kinase one or IRE1 is the most conserved eukaryotic unfolded protein response (UPR) receptor. It is a type I transmembrane protein kinase receptor with a distinctive site-specific RNase activity. As the binding mechanics of the misfolded proteins with the N-terminal domain of IRE-1 are unclear, three binding models — direct, indirect, and allosteric -- are proposed for receptor activation. Nevertheless, it is known that once a misfolded protein associates with IRE1, it...
2.4K
TGF - β Signaling Pathway
7.4K
The TGF-β signaling pathway regulates cell growth, differentiation, adhesion, motility, and development. TGF-β ligands that induce TGF-β signaling are synthesized in their latent form. Several proteases or cell surface receptors such as integrins act upon the latent form, releasing the active ligand. There are three types of mammalian TGF-βs: (TGF-β1, TGF-β2, and TGF-β3) that bind as homodimers or heterodimers to TGF-β receptors. The TGF-β receptors...
7.4K
Experimental RNAi
6.1K
RNA interference (RNAi) is a cellular mechanism that inhibits gene expression by suppressing its transcription or activating the RNA degradation process. The mechanism was discovered by Andrew Fire and Craig Mello in 1998 in plants. Today, it is observed in almost all eukaryotes, including protozoa, flies, nematodes, insects, parasites, and mammals. This precise cellular mechanism of gene silencing has been developed into a technique that provides an efficient way to identify and determine the...
6.1K
Receptor Downregulation in MVBs
2.1K
Multivesicular bodies (MVBs) are mature endosomes that sort ubiquitinated proteins and then fuse with lysosomes to degrade the sorted proteins. Epidermal growth factor (EGF) and its receptor (EGFR) form a complex that can be internalized through endocytosis, sorted into an MVB, and later degraded.
The EGFR can initiate signaling pathways that lead to cell proliferation, migration, and differentiation. Overexpression of EGFR stimulates cells to proliferate. Excessive EGFR...
The EGFR can initiate signaling pathways that lead to cell proliferation, migration, and differentiation. Overexpression of EGFR stimulates cells to proliferate. Excessive EGFR...
2.1K


